Adverse effects of androgen deprivation therapy in prostate cancer: Current management issues

Prostate cancer (CaP) is the most common visceral malignancy and a leading cause of cancer death in men. Androgen deprivation therapy (ADT) is an established treatment for locally advanced and metastatic CaP, and often used as primary therapy in select patients. As ADT has continued to assume an imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Bagrodia, Aditya, DiBlasio, Christopher J., Wake, Robert W., Derweesh, Ithaar H.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2009
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2710058/
https://www.ncbi.nlm.nih.gov/pubmed/19672340
http://dx.doi.org/10.4103/0970-1591.52907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2710058/
https://www.ncbi.nlm.nih.gov/pubmed/19672340
http://dx.doi.org/10.4103/0970-1591.52907

Ejemplares similares